IL2 and neoplasm: Treatment with TS/A (murine mammary carcinoma cells) exosomes were also shown to significantly inhibit the release of IFN-γ in IL-2-stimulated NK cells, suggesting that tumor exosomes could impair production of cytokines by activated NK cells [35].